The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday.
The FDA approved belantamab mafodotin-blmf in combination with bortezomib and dexamethasone for the treatment of certain ...
MedPage Today on MSN
FDA Approves GLP-1 Pill for Primary, Secondary Cardiovascular Protection
Semaglutide 7 mg and 14 mg tablets are now available for reducing the risk of cardiovascular death, heart attack, or stroke ...
Syndax Pharmaceuticals, Inc. ( NASDAQ: SNDX) Discusses FDA Approval of Revuforj for Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia October 24, 2025 2:30 PM EDT ...
The Food and Drug Administration approved revumenib, or Revuforj, from Syndax (SNDX) Pharmaceuticals, a menin inhibitor, for relapsed or ...
Assessing all available nonhormonal and hormonal therapies for vasomotor symptoms helps empower women to make informed ...
Reader's Digest Canada on MSN
30 Old-Time Home Remedies That Actually Work
Honey to heal a wound. Cherries for gout. Cod-liver oil— blech!—to keep your eyes healthy. Your grandmother and her doctors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback